Corporate calendar for BriaCell Therapeutics Corp. (BCTX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $91M | |
| 2026-09-15 | ||
| 2026-09-15 | $17M |
Stock Splits
| Date | Ratio |
|---|---|
| 2025-08-25 | 1:10 |
| 2025-01-29 | 1:15 |
| 2020-01-02 | 1:300 |
| 2014-12-03 | 307:1000 |
Price
| Price | $4.22 |
| Market Cap | $37M |
| Exchange | NASDAQ |
| Country | CA |
Related companies: ALLR · ASBP · CRIS · CTXR · ENTO · HOTH · LPTX
Explore sector: Healthcare · Biotechnology
More sections of BCTX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks